4th Antigen Specific Immune Tolerance Digital Summit (description)


Category:Health & Wellness
Address:Virtual Event , , United States of America
Event dates:1/27/2021 - 1/28/2021 (This event has already taken place)
Event web site:
findCE GPA: This event is not yet rated. Click here to view a sample report card
Click here to rate 4th Antigen Specific Immune Tolerance Digital Summit


Topics to be Covered:

  • Charlotte Fribert, Chief Executive Officer, Toleranzia AB, Jean Van Rampelbergh, VP Clinical and Regulatory, Imcyse, Jose Carballido, Executive Director (Translational Medicine/ Preclinical Safety), Novartis, Saso Cermerski, VP and Head of Discovery and Translation Immunology, Cue Biopharma, Karsten Sauer, Vice President of Immunology, Repertoire Immune Medicines, Li Zhang, Assistant Professor Medicine-Endocrinology, Baylor College of Medicine, Matthias Von Herrath, Vice President and Senior Medical Officer, Global Chief Medical Officer, Novo Nordisk
  • Pharmaceuticals
Organizer phone:
Offering type:Online
Specialty:Data not provided
Event frequency:Never
First Meeting:
Total events:
Est. attendance:
Target audience:Any
Other target audiences:
Host Sponsor:Hanson Wade
Est. # of exhibitors:
Currency:US Dollars
CE Credits:
Organizer URL


The 4th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building for antigen specific immunotherapies, ASIT 2021 will be the only antigen-specific summit offering thought-leading content to drive the field towards a more precise and ethical antigen-specific approach to drug development.

This is the industry's definitive antigen specific drug development forum.

Across 3 packed days, thought leaders from Novartis, ImCyse, Harvard Medical School, Toleranzia, Toralgen will reveal insight, data, and lessons learned from the last 12 months to enable you to hurdle the roadblocks preventing the development of clinically safe and effective antigen-specific immunotherapies for autoimmune and immune mediated disorders.

26-28 January, 2021
8am-6pm EST



8:00 am to 6:00 pm

Registration Fee Details:

Drug Developers (Earlybird rates and workshops available): USD 1999.00,
Academic (Earlybird rates and workshops available): USD 1799.00,
Solution Providers (Earlybird rates and workshops available): USD 2499.00

Other items that tuition includes:

Travel and hotel arrangements:

Contact Person:Antigen Specific Immune Tolerance Summit Team
Organizer State/Province: (Outside US)
Organizer CountryData not provided
Structural makeupData not provided
Host Sponsor; Other SponsorsHanson Wade
Event Site/VenueVirtual Event
Event sold out?No
Multiple locations or dates?No
Statistics available for most recent event held in:NA
Average number in event attendance of:
Number in attendance of:
Target BoundariesLocal
Is Registration contact information the same as Organizer Contact above?Yes
Web Page
Can one register for your CE on your web site?NA
Can registration be made by snail (regular) mail?Yes
Online housing reservations: 
Do you have additional written or AV materials for sale?No
If so, are they available for non-attendees as well as those attending?NA
Is full tuition necessary to ensure registration?No
Will there be shuttle service available?NA
Additional notes:


Sign In/Sign Out
About Us
Contact Us